T1	Participants 76 91	exuding wounds.
T2	Participants 273 314	exuding wounds greater than 2.5 x 2.5 cm.
T3	Participants 326 487	target population was 300 control and 300 test subjects across three sites in the UK, but recruitment difficulties resulted in only 125 patients being evaluable.
